Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP400711.RAIlGpeghydjXsgzyxbevTsNuhco4z2mUwGt4bi8QmnCA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP400711.RAIlGpeghydjXsgzyxbevTsNuhco4z2mUwGt4bi8QmnCA130_assertion type Assertion NP400711.RAIlGpeghydjXsgzyxbevTsNuhco4z2mUwGt4bi8QmnCA130_head.
- NP400711.RAIlGpeghydjXsgzyxbevTsNuhco4z2mUwGt4bi8QmnCA130_assertion description "[RT-PCR analysis demonstrated that TRP-2 was present in 51.2% of primary tumor cell lines derived from patients with glioblastoma multiforme (GBM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP400711.RAIlGpeghydjXsgzyxbevTsNuhco4z2mUwGt4bi8QmnCA130_provenance.
- NP400711.RAIlGpeghydjXsgzyxbevTsNuhco4z2mUwGt4bi8QmnCA130_assertion evidence source_evidence_literature NP400711.RAIlGpeghydjXsgzyxbevTsNuhco4z2mUwGt4bi8QmnCA130_provenance.
- NP400711.RAIlGpeghydjXsgzyxbevTsNuhco4z2mUwGt4bi8QmnCA130_assertion SIO_000772 12843792 NP400711.RAIlGpeghydjXsgzyxbevTsNuhco4z2mUwGt4bi8QmnCA130_provenance.
- NP400711.RAIlGpeghydjXsgzyxbevTsNuhco4z2mUwGt4bi8QmnCA130_assertion wasDerivedFrom befree-2016 NP400711.RAIlGpeghydjXsgzyxbevTsNuhco4z2mUwGt4bi8QmnCA130_provenance.
- NP400711.RAIlGpeghydjXsgzyxbevTsNuhco4z2mUwGt4bi8QmnCA130_assertion wasGeneratedBy ECO_0000203 NP400711.RAIlGpeghydjXsgzyxbevTsNuhco4z2mUwGt4bi8QmnCA130_provenance.